Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
National Institute of Allergy and Infectious Diseases (NIAID)
With
The primary objective of this trial is to determine the efficacy of interleukin-15 (IL-15) inhibition with AMG 714 at inducing facial repigmentation in vitiligo. The secondary objectives are to: * Evaluate the safety and tolerability of AMG 714 in vitiligo * Determine the efficacy of IL-15 inhibition with AMG 714 at inducing total body skin repigmentation in vitiligo * Assess the durability of the skin repigmentation achieved by AMG 714 in vitiligo * Evaluate the efficacy of AMG 714 followed by narrow band UVB (nbUVB) phototherapy
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted